π Pharmidex at Medicine at the Crick | New Frontiers in Drug Discovery π
November 18, 2024
We are excited to announce that
Pharmidex will be participating in the Medicine at the Crick | New Frontiers in Drug Discovery meeting! Our Head of Operations,
Ash Alavijeh, will be representing
Pharmidex at this prestigious event.
Ash is looking forward to connecting with fellow attendees, discussing the latest breakthroughs in drug discovery, and exploring opportunities for collaboration.
This meeting is a fantastic platform for exchanging ideas and advancing innovation in medicine come meet us and learn how Pharmidex’s expertise in preclinical research can support your drug discovery journey!
π
When: 18/11/2024
π Where: Francis Crick Institute
We can’t wait to see you there!

#Pharmidex #DrugDiscovery #MedicineAtTheCrick #Collaboration #Innovation

πβοΈβοΈ Congratulations to our Pharmidex team members who took part in the St Albans Summer Solstice 10K #BeatTheSunset ! It was great to see colleagues enjoying a fantastic summer evening while supporting their physical and mental wellbeing. At Pharmidex , we believe health extends beyond the laboratory and activities like these are a great way to stay active, connect with colleagues and have fun. Well done to everyone who took part and represented Pharmidex so positively!

A big thank you to our interns from City St George’s, University of London and heir fantastic contribution to Pharmidex over the past few months. They have supported scientific projects across the business, developed valuable technical skills and gained hands-on experience within a CRO environment. Their contribution has extended beyond the laboratory, helping with our website, marketing materials, conference preparation and business development activities. Science drives success, but communicating that science effectively is just as important. Our interns have helped us do both. Thank you for your hard work, enthusiasm, and dedication. We wish you every success in the next stage of your careers.

On 18 June, our COO, Ash Alavijeh , will join an industry panel discussing: "What are the advantages and disadvantages of working with UK-based Discovery CROs?" The session will explore the value of UK CROs in supporting innovation, protecting IP, accessing scientific expertise and accelerating drug discovery programmes. π
18 June 2025 π Cambridge π Panel Session: 12:20–12:45 We look forward to connecting with colleagues, collaborators, and innovators from across the life sciences community.




